OBIZUR

Antihemophilic Factor (Recombinant), Porcine Sequence

Takeda

OBIZUR, Antihemophilic Factor (Recombinant), Porcine Sequence, is an antihemophilic factor indicated for the treatment of bleeding episodes in adults with acquired hemophilia A. (1)

Limitations of Use:

• Safety and efficacy of OBIZUR has not been established in patients with a baseline anti-porcine factor VIII inhibitor titer of greater than 20 BU. (1)
• OBIZUR is not indicated for the treatment of congenital hemophilia A or von Willebrand disease. (1)

Store OBIZUR at refrigeration temperature of 2° to 8°C [36° to 46°F]. Do not freeze. Store vials in the original package to protect from light. Do not use beyond the expiration date printed on the carton or vial. Use OBIZUR within 3 hours after reconstitution. Discard any unused reconstituted product if not used within 3 hours after reconstitution. Do not use OBIZUR if the reconstituted solution is cloudy or has particulate matter.